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ABSTRACT 
 
Osteoarthritis (OA) is a major concern among healthcare providers as its 
increasing prevalence has not shaped sufficiently adequate therapies to slow or 
reverse the onset of OA.  Further, traumatic injury to joints in the young 
population can lead to early arthritic changes characteristic of the elderly 
population.  The spontaneous regeneration of injured articular cartilage (AC) is 
virtually non-existent and current treatments focus on pain management and 
reestablishing patient mobility.  No current treatments restore the AC surface to 
its pre-injured state, biomechanically or biochemically.  Cartilage tissue 
engineering has expanded the potential toolbox of treatment options.  Bone 
marrow derived mesenchymal stem cells (BMSCs) and chondrocytes are the 
most common cell sources for AC tissue engineering.  Yet, few studies have 
investigated the use of a co-culture model, combing both cell sources into one 
hydrogel.  In this study, swine BMSCs and chondrocytes were co-cultured (1:1 
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ratio) in a 2% sodium alginate hydrogel and implanted subcutaneously into the 
backs of old nude mice for 6 weeks.  For comparison, two other groups were 
designed to study the effectiveness of this co-culture model: BMSCs only and 
chondrocytes only.  A previous study with BMSCs grown in chondrocyte 
conditioned media was also evaluated with the co-culture groups.  All groups 
(n=4) spent 2 weeks in vitro under the influence of chondrogenic differentiation 
media prior to implantation.  Histological examination showed extracellular matrix 
formation in all gels.  The BMSCs only group showed the continuous formation of 
matrix, while the co-culture group showed isolated pericellular matrix.  The 
conditioned BMSCs showed the most continuous matrix formation.  Not 
surprisingly, glycosaminoglycan (GAG) and hydroxyproline assays reported the 
chondrocyte gel group as the most biochemically active.  The co-culture group 
produced the lowest amounts of GAG and hydroxyproline.  This study shows that 
BMSCs and chondrocytes co-cultured in a 1:1 ratio does not provide a significant 
advantage in cartilage matrix production in comparison with BMSCs and 
chondrocytes cultured separately.  Further studies on the proper ratio and in vitro 
conditions will be the next step in defining a model for co-culture of BMSCs and 
chondrocytes.  
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INTRODUCTION 
Articular Cartilage 
 Cartilage is a highly specialized tissue found throughout the body serving 
many functions.  There are three classification types -  elastic, fibro-, and hyaline 
cartilage.  Hyaline cartilage is a subtype of cartilage that has many implications in 
the field of orthopedics.  It is found on the ends of long bones such as the femur, 
tibia, and humerus; lining the articular surfaces of all diarthrodial joints.  It 
provides mechanical compressive support as our joints experience weight-
bearing and load-bearing forces during activity and movement (Mow et al., 1989). 
 Articular cartilage (AC) is composed of four distinct zones: superficial, 
middle, deep and calcified (Figures 1 & 2).  Each zone is characterized by the 
density and shape of chondrocytes as well as the orientation of type II collagen 
fibers.  The superficial, or tangential, zone comprises approximately 10-20% of 
the AC thickness and is responsible for providing a smooth surface for ease of 
joint movement.  The collagen fibers in the superficial zone are tightly arranged in 
a parallel manner to the surface (Pearle et al., 2005).  The chondrocytes in this 
layer produce little proteoglycans compared to chondrocytes in the other zones 
of cartilage.  Instead, they produce proteins for surface lubrication (Wong et al., 
1996).  Chondrocytes in this layer tend to be flatter or more elongated than those 
in the other three layers.  The layer of cartilage deep to the superficial layer is the 
middle zone.  Here, the collagen fibrils are less organized, thicker and arranged 
in a non-parallel fashion with respect to the surface.  The middle zone normally 
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makes up about 40% to 60% of the AC layer.  The next 30% is called the deep 
zone and chondrocytes here produce large amounts of proteoglycans.  This layer 
also has the least amount of water, giving it the highest compressive modulus.  
Chondrocytes in this zone are easily identifiable due to their “stacked” 
arrangement aligned perpendicular to the subchondral bone.  Collagen fibers in 
this zone are larger in diameter and arrange themselves perpendicularly to the 
articular surface (Pearle et al., 2005).  The deepest zone, called the calcified 
zone, is situated directly on top of the subchondral bone.  The calcification results 
from accumulating apatitic salts which surround the chondrocytes.  The deep and 
calcified zones are separated by a tide mark.  The spatial arrangement of 
chondrocytes and collagen fibers largely determines the compressive modulus of 
each zone, increasing as you approach subchondral bone from the superficial 
zone (Pearle et al., 2005). 
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Figure 1: Articular Cartilage Structure.  A, cellular organization in zones of 
articular cartilage; B, collagen fiber orientation (Sophia Fox, Bedi, & Rodeo, 
2009) 
 
 
 
Figure 2: Swine articular cartilage stained in H&E (left) and Safranin-O 
(right).  Comparison with the diagram shown in Figure 1 indicates the 
organization of the chondrocytes from the superficial zone to the deep zone.  
Tick marks are measured in millimeters.  
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The resident cell in articular cartilage is the chondrocyte and it is a highly 
specialized cell that plays a unique and important role in the development, 
maintenance, and repair of the extracellular matrix (ECM) (Alford & Cole, 2005a).  
Each chondrocyte is responsible for turnover and maintenance of the ECM which 
directly surrounds the cell.  Consequently, chondrocytes are quite active, yet 
receive no blood supply, lymph drainage or nervous input.  The water content of 
AC allows for the exchange of nutrients, gasses and waste products through 
diffusion.  The normal mechanics of weight-bearing or load-bearing stresses on 
the AC present pressure differentials within the ECM, assisting gas, nutrient, and 
waste exchange (Athanasiou et al., 2001).  In mature cartilage, chondrocytes 
have encapsulated themselves within the ECM in structures called lacunae 
(Figure 3).  This is why chondrocytes don’t appear to move after full development 
of the AC layer.  Chondrocytes whose lacunae develop closely together form 
isogenous groups (Figure 3) (Kheir & Shaw, 2009). 
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Figure 3: Hematoxylin and eosin stain of hyaline cartilage.  The matrix 
regions are addressed above.  Pericellular matrix is identified as the dark line 
directly adjacent to the outter edge of each lacuna.  (Source: 
http://www.dartmouth.edu/~anatomy/Histo/lab_2/bone/DMS065/popup.html) 
 
In AC, type II collagen provides the majority of the shear and tensile 
properties unique to hyaline cartilage, representing 90%-95% of the collagen 
(Buckwalter & Mankin, 1998).  While other types of collagens are present, they 
merely help stabilize the type II collagen network (Buckwalter et al., 2005).  The 
triple helix structure of type II collagen is the most influential physical 
characteristic on the shear and tensile properties of AC (Fox et al., 2009).  These 
positively charged type II collagen fibrils are intertwined with the negatively 
charged proteoglycans.  On a standard hematoxylin & eosin (H&E) stain (Figure 
3), varying levels of proteoglycan distribution within the ECM are evident through 
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the gradient of hematoxylin staining around the lacunae (Fox et al., 2009).  The 
dark-staining thin layer surrounding the cell is the pericellular matrix and consists 
of mostly proteoglycans.  It has been hypothesized that this layer is important for 
the initiation of signal transduction during load bearing events (Eggli et al., 1985).  
Surrounding the pericellular matrix is the territorial matrix, which has an extensive 
fine collagen fibril network.  This region is much thicker than the pericellular 
matrix (Guilak & Mow, 2000).  It is also believed that this network is essential for 
mechanical protection of the chondrocytes during load-bearing instances 
(Buckwalter et al., 2005).  The interterritorial matrix makes up the largest part of 
the matrix regions.  Here, the collagen fibrils are larger and arranged in random 
bundles similar to that described by the zones (Figure 1B). 
 Proteoglycans are the second most abundant macromolecule in the ECM.  
They consist of a protein core with 1 or more glycosaminoglycans (GAGs) 
attached (Buckwalter & Mankin, 1998).  Glycosaminoglycan chains are 
composed of many monosaccharides that exhibit charge repulsion creating a 
“distended state” (Newman, 1998).  GAG side chains carry large amounts of 
negative charge, creating a hydrophilic environment for the high water content 
(60%-80%) that helps AC resist compressive loads (Alford & Cole, 2005a).  
Chondroitin sulfate, keratin sulfate, hyaluronic acid, and dermatin sulfate are the 
most common GAGs found in AC.  Each one’s concentration varies with 
increasing age, traumatic injury, and disease (Buckwalter et al., 2005). 
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Aggrecan is the major proteoglycan in AC consisting of one hundred chondroitin 
sulfate and 50 keratan sulfate GAG chains bound to a protein core.  Many 
aggregan molecules attached to a hyaluronic acid molecule make up a 
proteoglycan aggregate (Figure 4) (Buckwalter et al., 2005). 
 
 
 
Figure 4: Proteoglycan aggregate and aggrecan molecule (Pearle et al., 
2005).  Aggrecan is composed primarily of chondroitin sulfate and keratin sulfate 
attached to a protein core.  Chondroitin sulfate and keratin sulfate carry large 
amounts of negative charges and repel one-another.  This gives the proteoglycan 
aggregate a large volume with which to attract water. 
 
Injury & Osteoarthritis 
Degradation and loss of the AC layer is commonly known as osteoarthritis 
(OA).  Generally, OA is a degenerative joint disease whereby loss of hyaline 
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cartilage can result in severe pain and limited mobility (Alford & Cole, 2005a).  
The progression of this disease results in both mechanical and biochemical 
changes, affecting the overall health and utility of the joint.  Macroscopically, the 
earliest evidence of OA may be “fraying” of the AC surface. 
Two of the most common ways in which the integrity of hyaline cartilage is 
lost is through traumatic injury and normal aging.  Traumatic injury to the articular 
surface can often lead to chondral lesions that can further degenerate (Messner 
& Maletius, 1996).  Partial lesions do not heal and full-thickness lesions of AC 
can lead to fibrocartilage invasion.  Fibrocartilage formation is a response that 
fills the void left by a lesion yet lacks the resiliency of normal AC, both 
mechanically and biochemically (Brittberg et al., 1999).  Depending on the extent 
of the lesion, injury may also lead to decreased normal shear stresses in the 
knee, which is the main source for pressure gradients necessary for appropriate 
nutrient and waste exchange (Athanasiou et al., 2001). 
The articular lesions created by this aging process only heal partially, if at 
all (Hunziker, 2002).  Biochemically, the progression in OA is directly proportional 
to the loss of proteoglycan content and composition.  A larger percentage of 
nonaggregated proteoglycans exist via proteolytic degradation.  The decrease in 
proteoglycan aggregates is accompanied by a decrease in the GAG chains 
resulting in a larger influx of water.  At the same time, the collagen network 
becomes less organized, possibly aiding in the increased water concentration 
among the spread out aggrecan molecules.  Cumulatively, these changes 
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decrease the overall stiffness of the hyaline cartilage matrix through an increase 
in water permeability (Akizuki et al., 1987; Buckwalter et al., 2005).   The high 
water content and decreased stiffness result in a softening of the articular layer 
known clinically as chondromalacia (Bentley, 1970).  Collagen changes in AC 
during progression of OA result mostly in decreased organization, unlike 
proteoglycan changes where we see decreased content and formation of 
aggregates. 
At the cellular level, chondrocytes proliferate around the area of increased 
osmolarity.  With increased proliferation, there is an increase in matrix 
production.  Interestingly, there is a simultaneous release of metalloproteases 
which degrade newly synthesized and existing matrix components (Gillogly et al., 
1998).  Overall, increased matrix production outweighs the activity of the 
metalloproteases and can lead to stabilization of the articular surface, delaying 
the spread of OA (Buckwalter et al., 2005). 
With advancing age, there is an increasing prevalence of osteoarthritis.  
The pathological progression results in the eventual loss of the articular cartilage 
layer, exposing the underlying bone surface.  In the knee, the loss of articular 
cartilage creates bone-on-bone contact, often resulting in chronic pain and 
limited mobility.  OA is a growing concern among chronic diseases, currently 
affecting an estimated 50 million adults in the United States.  Projections 
estimate an increase towards 67 million by 2030 (Hootman & Helmick, 2006). 
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Surgical Treatment 
In the United States as of 2009, it is estimated that OA accounts for over 
$185 billion combined out-of-pocket and insurer expenditures (Kotlarz et al., 
2009).  OA can be attributed to other primary healthcare concerns such as 
diabetes and obesity.  Further, OA ranks fourth in hospitalization causes (Murphy 
& Helmick, 2012).   Cartilage replacement surgeries account for more than 1 
million surgical procedures each year (Langer & Vacanti, 1993). 
Among these surgical procedures, microfracture (MF) is a popular surgical 
technique currently used to treat cartilage damage.  MF surgery aims to grow 
new cartilage by creating a blood supply to the damaged area, which is achieved 
by punching holes in the underlying bone to induce bleeding and thus expose 
bone marrow cells to the articular surface (“Articular Cartilage Restoration - 
OrthoInfo - AAOS,” n.d.).  As previously mentioned, the new tissue produced is 
mostly fibrocartilagenous and inferior to the previous tissue.  MF provides 
temporary relief at best by delaying the onset or progression of arthritic changes.  
Strict patient compliance is needed post-operatively in order to achieve the best 
outcomes (Alford & Cole, 2005b).   
Another technique employed is autologous chondrocyte implantation (ACI) 
in which cartilage from a non-weight bearing portion of the distal femur is 
removed and digested to yield chondrocytes.  The chondrocytes are cultured in 
the lab and then injected back into the original defect.  Often, periosteum taken 
from the proximal tibia is used to cover the area where chondrocytes were 
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injected.  Donor site morbidity and low chondrocyte acquisition are common 
problems encountered with ACI.  Further, this course of treatment requires two 
major invasive surgeries only a few weeks apart (Alford & Cole, 2005b). 
Osteoarticular transfer system (OATS) is another widely used surgical 
treatment for chondral lesions.  In this autograft technique, damaged cartilage is 
removed with a biopsy punch of variable diameters.  Another biopsy punch is 
used to obtain a similarly sized osteochondral plug from a non-weight bearing 
portion of the distal femur and transplanted into the site of the original injury.  The 
idea that healthy cartilage now replaces the same previously damaged area is 
the main proponent of this technique (Hangody et al., 2008).  Yet, frequently the 
plugs transplanted do not fit the exact contour of the injured area of the condyle 
of the distal femur, resulting in graft failure and pain due to improper surface 
contact with the meniscus and tibial plateau (Garretson et al., 2004).  Similarly, if 
a cartilage defect covers a significant portion of an articular surface, a mosaic 
OATS procedure can be employed.  Yet it is difficult to construct the contour of 
the articular surface with multiple osteochondral plugs (Cain & Clancy, 2001; 
Pearce et al., 2001). 
 
Tissue Engineering 
  Langer and Vacanti identified tissue engineering as  
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“… an interdisciplinary field that applies the principles of 
engineering and the life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue 
function.” (Langer & Vacanti, 1993).   
 
Tissue engineering presents a field where the current therapy shortfalls and 
costs can be overcome.  
 Tissue engineering aims to create new tissue, termed neotissue, using 
cells suspended with a scaffold material.  Probably the biggest challenge in the 
field of tissue engineering is constructing a scaffold that can be durable and 
resilient yet be broken down over time and eventually be replaced by the ECM 
made from cells suspended within the scaffold.  Further, the perfect scaffold must 
be able to provide adequate cell nutrition or diffusion of nutrients in order to 
maintain high cell viability over the course of neocartilage formation.  Thus, a 
good scaffold must be able to act as an intermediate ECM while the cells adapt 
to their new physiological environment (Rowley et al., 1999).     
 Tissue engineering of cartilage most commonly utilizes chondrocytes and 
mesenchymal stem cells as cell sources.  Chondrocytes represent an obvious 
choice for cells since they already express the necessary matrix components of 
AC (Chung & Burdick, 2008).  Chondrocyte acquisition can be adversely affected 
in instances of elderly patients, limited donor sites or loss of chondrocyte 
phenotype during in vitro culture, requiring another source of cells (Tuan et al., 
2003).  In support, mesenchymal stem cells are a popular choice for their intrinsic 
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renewability and capacity to differentiate towards the chondrogenic lineage 
(Cancedda et al., 2003).   
 Scaffolds have the ability to provide expression of desirable phenotypes 
within a certain cell lineage in addition to supporting cell attachment and 
migrations (Table 1) (Danišovič et al., 2012).  
 
Table 1. Type of biomaterials used in cartilage tissue engineering (Table 
adapted from Danišovič et al., 2012). 
 
Natural Polymers Synthetic Polymers 
Aragose 
Alginate 
Cellulose 
Collagen 
Chitosan 
Chondroitin Sulfate 
Fibrin Glue 
Gelatin 
Hyaluronic Acid 
Silk Fibroin 
Poly (α-hydroxy esters) 
Poly (ethylene glycol/oxide) 
Poly (NiPAAm) 
Poly (propylene fumarate) 
Poly (urethane) 
Poly (vinyl alcohol) 
 
 
Alginate 
 Brown algae are the main source for alginate used in tissue engineering 
and was first discovered and characterized by Stanford in 1883 (Mautner, 1954).  
Alginate gels have long been used in the food (Steinbüchel & Rhee, 2005) and 
paper (Augst et al., 2006) industries as emulsifiers  and shear thinning agents 
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respectively.  Further, alginate has become popular in the pharmaceutical 
industry as a drug delivery mechanism (Ciofani et al., 2002).   
The structural unit that comprises the alginate polysaccharide are two 
guluronic acid (G) and two mannuronic acid (M) residues connected via (1,4)-
linkages (Figure 4) (Augst et al., 2006).  -The amount and sequence of the G and 
M residues is variable and depends on the source of the alginate (Martinsen et 
al., 1989).  Divalent cations, commonly Ca2+, are used to ionically cross-link 
adjacent polymer chains by interacting with the carboxylic acid groups of G-
blocks (Augst et al., 2006).   
 
 
Figure 5: Chemical structure of alginate. Shows two guluronic acid (G) 
monomers and 2 mannuronic acid (M) monomers in a chain (Drury et al., 2004) 
 
The stiffness, swelling and degradation rates of alginate are variable, 
producing a customizable hydrogel with tissue specific applications (Augst et al., 
2006).  Many of these properties are controlled by gelation rate, which is 
determined by the cross-linker used (Kuo & Ma, 2001).  Calcium chloride (CaCl2) 
and calcium carbonate (CaCO3) solutions have been a popular source for 
calcium ions required in the ionic cross-linking of alginate (Kuo & Ma, 2001).  
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They have differing water solubilities and therefore different diffusion rates 
through the alginate solution, ultimately affecting the gelation rate.  Slower cross-
linking results in enhanced mechanical properties (Augst et al., 2006).  
Alternatively, alginate can be covalently cross-linked by carbodiimides, resulting 
in slower degradation times (Rowley et al., 1999).  In tissue engineering, alginate 
hydrogels represent a favorable scaffold due to their biocompatibility and non-
immunogenicity (Gu et al., 2004; Silva et al., 2006). 
  
Specific Aims/Objectives 
From previous studies, it is apparent that a successful AC engineered 
replacement is one that will be able to withstand the normal mechanical loads 
experienced by the knee throughout daily activities.  Current research has yet to 
generate AC that has the compressive properties of adult tissue.  Furthermore, 
there seems to be a connection between the type of scaffold that is used to 
deliver the cells and their ultimate resiliency in vivo.  Limited research has 
questioned the efficacy of delivering chondrocytes and bone-marrow derived 
mesenchymal stem cells (BMSCs) in one gel.  It is plausible that chondrocytes 
cultured with BMSCs in alginate can produce a neocartilage comparable to 
chondrocytes or BMSCs alone.  It is hypothesized that chondrocytes will aid in 
directing BMSCs toward their chondrogenic potential while simulatenously 
producing ECM products.  Combining BMSCs with chondrocytes minimizes the 
strict requirements of ACI therapies where chondrocytes are the only cell source.  
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The goal of this study was to assess the utility of alginate as a model hydrogel for 
AC tissue engineering in conjunction with use and viability of BMSCs co-cultured 
with chondrocytes as a hybrid cell source.  Histological and biochemical 
evaluation of the chondrogenic capacity of BMSCs and subsequent collagen II 
matrix production within a sodium alginate hydrogel will be discussed.  The 
results of this study will be compared to a previous alginate experiment in which 
BMSCs were cultured in chondrocyte conditioned media. 
 
Table 2: Overview of Alginate Gels 
Study Group Timepoint Size 
Co-Culture 
Study 
BMSCs Experimental 
6 weeks 
in vivo 
4 
Chondrocytes (+) control 
BMSCs/Chondrocytes 
(1:1 ratio) 
Experimental 
Conditioned 
Media Study 
BMSCs (conditioned 
media prior to gel 
seeding) 
Experimental 
5 weeks  
in vivo 
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MATERIALS AND METHODS 
Overview 
 All procedures were approved by the Institutional Animal Care and Use 
Committee of Massachusetts General Hospital.  Sterility was maintained 
throughout all stages of the experiment.  Briefly, swine articular chondrocytes 
and BMSCs were isolated and cultured.  BMSCs and chondrocytes were 
suspended within a 2% sodium alginate hydrogel constructs and cultured in vitro 
under chondrogenic differentiation media for two weeks.  After two weeks in vitro, 
constructs were implanted subcutaneously in nude mice for 6 weeks. 
 
Cell Isolation and Culture 
 Knees were harvested from two 4-month-old Yorkshire swine (40 kg).  The 
femoral and patellar articular cartilage layer was removed using a no. 10 surgical 
blade (Bard-Parker, Dublin, Ohio).  The cartilage was chopped into 1 mm3 chips 
and digested for 18 hours in 0.1% collagenase type 2 (Worthington Biochemical, 
Freehold, NJ), F-12 HAM (Gibco, Grand Island, NY) and 1% antibiotic 
antimycotic solution (Sigma, St. Louis, MO).  The suspension was passed 
through a sterile 100 μm filter (Becton Dickinson, Franklin Lakes, NJ) to remove 
any undigested tissue.  Cells were then centrifuged at 250 g’s for 10 minutes.  
The supernatant was aspirated and the cell pellet was resuspended in 
chondrocyte media (CM) consisting of F-12 HAM, 1% antibiotic antimycotic 
solution, 10% Fetal Bovine Serum (FBS) (Gibco), 50 μg/ml L-ascorbate (Sigma) 
 18 
and 1% non-essential amino acids (Gibco).  The cells were centrifuged and 
washed twice more.  Cell number and viability were determined using the 
hemocytometer and trypan blue method.  Chondrocytes were finally plated at a 
density of 10,000 cells/cm2 in 150 cm2 tissue culture treated flasks (BD Falcon, 
Bedford, MA) with 25 mL of CM and incubated at 37˚C and 5% CO2 under 
humidified conditions.  This culture period was identified as passage 0 (P0), 
since cells had not yet been split.  Media was changed twice weekly. 
 Additional Yorkshire swine knees were harvested for bone marrow 
processing.  The soft tissue and muscle layers were carefully removed to expose 
the distal femur and proximal tibia.  A sterile saw was used to cut 1 cm off of the 
distal femur and proximal tibia.  Bone curretts were used to scrape the interior of 
the trabecular bone on both sides of the cut.  Bone fragments were collected in 
0.9% saline and chopped with sterile scissors until no large fragments existed.  
The mixture was then passed through 3 layers of sterile gauze and 100 μm filters 
to remove any remaining large bone fragments.  The remaining solution was then 
plated in 150 cm2 tissue culture flasks in 10 mL aliquots.  BMSC media (10% 
FBS, high glucose DMEM, 1% antibiotic antimycotic solution, and 50 μg/ml L-
ascorbate) (15 mL) was added to each flask (P0).  Flasks were placed in a 37°C 
humidified incubator with 5% CO2.  After one week, flasks were washed with 10 
mL of phosphate-buffered saline (PBS) twice and refilled with 25 mL of BMSC 
media.  Media was changed twice weekly.  BMSCs were trypsined and replated 
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at 10,000 cells/cm2 (P1).  Cells were grown and trypsined until the end of the 
third passage (P3). 
 In a separate previous experiment, BMSCs were isolated as described 
above and cultured until P3.  During the P3 phase, the cells were cultured with 
conditioned media from chondrocytes.  P0 chondrocytes were harvested and 
plated into 150 cm2 flasks at a cell density of 10,000 cells/cm2.  Chondrocytes 
were cultured with BMSC media instead of CM.  Media was changed twice 
weekly and old media was stored for use on P3 BMSCs.  Conditioned media was 
fed to BMSCs during the entire P3 culture period, which lasted 7 days. 
 
Devitalized Ring Creation 
 Devitalized cartilage rings were used to mold the alginate gel.  Knees 
were harvested from 4-month-old Yorkshire swine.  Subcutaneous tissue and 
muscle were carefully removed to expose the femoral condyles and patellar 
groove.  Osteochondral plugs were collected from the distal femur using an 8.5 
mm surgical biopsy punch (Acufex, Smith & Nephew, Memphis, TN).  Cartilage 
discs were created by using a custom designed cutting block, removing the bone 
layer from the original osteochondral plugs.  A disposable biopsy punch (Miltex, 
Integra, Plainsboro, NJ) was used to create a ring with a 6 mm inner diameter.  
Cartilage rings were placed in PBS (Sigma) with 1% antibiotics and exposed to a 
minimum of five freeze-thaw cycles in order to kill the chondrocytes.  Rings were 
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stored at -20˚C until gels were made.  Final dimensions of the devitalized ring 
were 8.5 mm outer diameter, 6 mm inner diameter and 2.25 mm thick. 
 
Alginate Gel Creation 
Sodium alginate powder, Pronova UP LVG (NovaMatrix, Sandvika, 
Norway), was dissolved in 0.9% saline to create a 2% (weight) alginate solution.  
The solution was vortexed and placed in a 37°C incubator for 30 minutes.  The 
alginate gel was then filtered using a 20 μm sterile syringe filter (Corning 
Incorporation, Corning, NY).  Three alginate gel groups were organized for the 
experiment (n=4): BMSCs only, BMSCs and chondrocytes in a 1:1 ratio, and 
chondrocytes only.  Chondrocytes in culture flasks were removed with 0.05% 
Trypsin-EDTA (Gibco).  Collected cells were washed twice with PBS and 
centrifuged at 250 g’s for 10 minutes.  BMSCs were collected from the culture 
flasks in a similar fashion.  The supernatant was discarded and the cell pellets 
resuspended in the 2% alginate gel at a concentration of 40 million cells per mL 
for each of the three experimental groups.  Devitalized cartilage rings were 
thawed to room temperature and 10 μL of 10% calcium chloride solution (w/v) 
was pipetted into each ring construct.  Then 100 μL of the alginate-gel solution 
was pipetted into each devitalized ring and another 10 μL 10% calcium chloride 
was pipetted on top of the alginate gel.  Gels were allowed to set for 15 minutes 
at 37˚C and then placed into individual wells of a 24-well plate.  Each well was 
filled with 1 mL StemPro Chondrogenic Differentiation media (Gibco) and 
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cultured at 37˚C and 5% CO2 for two weeks under humidified conditions.  
Differentiation media was changed twice weekly until implantation. 
The alginate gel creation for the chondrocyte conditioned BMSCs (n=4) 
was the same as just described except devitalized ring models were not used.  
Instead, alginate gel molds were formed using 1 mL polypropylene 
microcentrifuge tube (Fisher Science).  These gels experienced the same in vitro 
culture conditions. 
 
Implantation and Harvest 
 Under sterile surgical technique, gels were implanted subcutaneously into 
the backs of 6-week old nude mice (Massachusetts General Hospital, Boston, 
MA).  Alginate co-culture study gels were harvested at 6 weeks and initially 
evaluated macroscopically.  Alginate gels seeded with chondrocyte conditioned 
BMSCs were harvested at 5 weeks and also initially evaluated macroscopically.  
Conditioned BMSCs were not left in vivo for 6 weeks due to time constraints.  All 
constructs from each group (n=4) were used in histological and biochemical 
evaluation.   
 
Histological Evaluation 
 One fourth of each construct was used for histological evaluation by 
hematoxylin and eosin (H&E), toluidine blue, and safranin-O staining.  After 
harvest, one-fourth of each construct was fixed in 10% phosphate buffered 
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formalin (Fisher Scientific) for 18 hours.  Formalin was replaced with PBS prior to 
embedding and staining.  Samples were paraffin embedded and stained with 
H&E for overall evaluation of neocartilage of the samples.  Samples were stained 
with toluidine blue and safranin-O in order to evaluate the GAG content of the 
engineered tissue.  Toluidine blue and safranin-O are charged dyes and 
therefore bind to negatively charged GAGs, revealing the relative synthesis of 
this ECM component. 
 
Biochemical Evaluation 
 One-fourth of each construct was used to evaluate the sulfated 
glycosaminoglycan content using Blyscan sGAG Assay kit (Biocolor, 
Carrickfergus, UK).  Briefly, samples were digested in papain extraction reagent 
(150 μg/mL papain; 200 mM sodium phosphate buffer, pH 6.4; 10mM sodium-
EDTA; and 5mM cysteine-HCl) for 18 hours overnight at 65˚C.  Additionally, 
hydroxyproline content was measured on one-fourth of each construct using a 
hydroxyproline colorimetric assay kit (Biovision, San Francisco, CA).  Samples 
were homogenized using a motorized homogenizer, Tissue Ruptor (Qiagen, 
Hilden, Germany), and exposed to acid hydrolysis (concentrated HCl) at 120˚C 
for 3 hours.  Swine AC served as the positive control and was included in the 
assay for sGAG and hydroxyproline.  Partial constructs were weighed (wet 
weight) prior to each test. 
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Statistical Analysis 
 A Student t-test was performed among the biochemical data collected in 
this study.  An alpha value of 0.05 was used for statistical significance and all 
values are reported as the mean ± standard deviation. 
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RESULTS 
 
Macroscopic Evaluation 
 The alginate gels within the devitalized ring model were harvested at the 
end of 6 weeks in nude mice and presented in Figure 6 below.  The gels 
appeared to maintain their shape and volume within the devitalized cartilage ring.  
Evidence of a possible neocartilage formation is seen in all samples, to varying 
degrees, within the chondrocyte-BMSC and BMSC groups.  Inflammation and 
scar tissue was not present at the time of sample harvest. 
  
 
 
Figure 6:  Macroscopic appearance of alginate hydrogel after 6 weeks in 
vivo.  Gross appearance of chondrocytes (top left); chondrocytes and BMSCs 
co-cultured (top right); and BMSCs (bottom) in alginate gel. 
 
 The alginate gels with chondrocyte conditioned BMSCs were harvested 
after 5 weeks and indicated in Figure 7 below.  Possible neocartilage formations 
is evidenced by the white opaque accumulations, but were not continuous 
throughout the gel.  Upon touch, there seemed to be some calcifications present.  
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Likewise, there were no signs of inflammation or scar tissue buildup in the area 
of sample harvest.   
 
  
Figure 7: Macroscopic appearance of alginate gels with chondrocyte 
conditioned BMSCs (5 weeks in vivo).  Neocartilage formation is readily 
apparent upon gross evaluation although not continuous throughout the gel.  Tick 
marks indicate 1 mm.   
 
Histological Evaluation 
 Alginate gels stained with H&E showed formation of ECM as evidenced by 
basophilic (purple) staining (Figures 10-13).  Further, presence of sGAG was 
noted with the staining of samples with toluidine blue and safranin-O.  It should 
be noted that safranin-O samples were understained, diminishing the red color in 
order to show sGAG accumulation.  Safranin-O staining in the chondrocyte 
conditioned BMSCs showed the deepest staining at 5 weeks (Figure 11).   
Figures 8 and 9 clearly demonstrate integration of the neotissue with the 
devitalized cartilage ring.  The neocartilage formed by the BMSC gel was 
continuous throughout the partial sample used for histological evaluation, unlike 
the other two groups in the co-culture study (Figure 8).   
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Similar results were seen in conditioned media BMSC gels (Figure 11).  
Alternatively, in the chondrocyte gels, ECM accumulation resulted in cell “islands” 
of neocartilage, best evidenced in the toluidine blue stain (Figure 9, middle).  The 
continuous nature of neocartilage in the H&E and safranin-O sections (Figure 9) 
were only seen in the pictured sections.  While the experimental group, 
chondrocytes and BMSCs, did not show integration with the cartilage ring or 
neocartilage formation similar to other groups, evidence of cellular lacunae can 
be seen microscopically (Figure 10).  Further, ECM production is indicated within 
each lacuna. 
Except for the understained safranin-O sections, native cartilage staining 
was less intense due to the devitalization process by way of repeated freeze-
thaw cycles.  Cellular morphology appears normal for chondrocyte phenotype in 
all samples except for the conditioned BMSCs (Figure 11).  Despite the most 
intense staining for ECM products, the cells in these gels retain a slight spindle-
like morphology more closely associated with fresh BMSCs and not fully 
differentiated chondrocytes.   
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Figure 8: Histological presentation of BMSCs in alginate gel (6 weeks in 
vivo).  Cross sections of alginate gels showing integration of devitalized cartilage 
ring (DC) with engineered cartilage (EC) in H&E (left), toluidine blue (middle), 
safranin-O (right).  Staining for safranin-O was less than ideal, but integration 
with the DC ring is evident in all three stains.  Scale bar is in μm. 
 
 
 
 
Figure 9: Histological presentation of chondrocytes in alginate gel (6 weeks 
in vivo).  Cross sections of alginate gel showing integration of engineered 
cartilage (EC) with devitalized cartilage ring (DC) stained with H&E (left), 
toluidine blue (middle), and safranin-O (right).  Most of the ECM produced by the 
chondrocytes resulted in a gel in microscopic appearance most similar to the 
toluidine blue stained section.  The continuous EC cartilage pictured in the H&E 
and safranin-O sections were not evident anywhere else.  Scale bar is in μm. 
 
 
 
DC 
DC DC DC 
DC DC 
EC EC EC 
EC EC EC 
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Figure 10:  Histological presentation of swine chondrocytes and BMSCs 
co-cultured in alginate gel (6 weeks in vivo).  Cross sections of alginate gel 
showing gel only stained with H&E (left), toluidine blue (middle), and safranin-O 
(right).  Strict lacunae formation is evident although no continuous neocartilage 
formation was present.  Pericellular ECM production is evident through the purple 
(left), blue (middle), and faint red (right) staining around each of the cells.  These 
gels had to be sectioned several times before any gel could be surveyed.  Scale 
bar is in μm. 
 
 
 
Figure 11:  Histological presentation of BMSCs cultured in chondrocyte 
conditioned media (5 weeks in vivo).  Cross sections of alginate gels stained 
with H&E (Left), toluidine blue (middle), and safranin-O (right).  Abundant ECM 
production resulted in continuous neocartilage formation.  It should be noted that 
these gels produced the best ECM in one less week than the co-culture group 
gels were able to produce.  Safranin-O staining for sGAG was the most intense 
in these gels.  Scale bar is in μm. 
 
 
 
 
 29 
Biochemical Evaluation 
 GAG Assay.  Glycosaminoglycan levels present in the alginate gels at 6 
weeks were significantly lower than that of native cartilage (Figure 12).  Swine 
chondrocytes encapsulated within alginate showed the greatest amounts of 
sGAG produced, at 10.58±3.85 μg/mg wet tissue.  BMSCs cultured with 
chondrocytes produced the lowest amount of sGAG (4.83±.69 μg/mg wet tissue).  
Intrestingly, the 5 week samples of chondrocyte chonditioned media alginate gels 
yielded the most sGAG of all samples with BMSCs (6.13±2.19 μg/mg wet tissue), 
but still about 10.6% that of native cartilage. 
 
 
 
Figure 12:  sGAG content in alginate hydrogels and native cartilage at 6 
weeks in vivo unless otherwise noted (presented in μg/mg of wet tissue).  
Exact values are indicated within each group column.  Bars indicate one 
standard deviation.  There were no significant differences between the 
BMSCs/Chondrocytes, BMSCs, or conditioned media gels (p>0.05).  Significant 
differences were found between the chondrocytes group and 
BMSCs/Chondrocytes, BMSCs and conditioned media groups (p<0.05).  ($= 
p>0.05; #= p<0.05; *= p<.001). 
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 Hydroxyproline Assay.  Hydroxyproline content in the alginate gels was 
relatively low at 6 weeks, with all groups measuring less than 2 μg/mg wet tissue 
(Figure 13).  Chondrocyte conditioned BMSCs showed the most hydroxyproline 
content of all groups with BMSCs (1.02±0.42 μg/mg wet tissue) despite spending 
one week less in vivo.  Chondrocytes within alginate produced hydroxyproline 
levels similar to that of native cartilage (1.91±0.94 μg/mg wet tissue).   
 
 
 
Figure 13: Hydroxyproline content in alginate hydrogels and native 
cartilage at 6 weeks in vivo unless otherwise noted (presented in μg/mg of 
wet tissue).  Exact values are indicated within each group column.  Bars indicate 
one standard deviation.  The only measured values reported as insignificant 
(p>0.05) were those between the BMSCs and BMSC/chondrocyte groups.  ($= 
p>0.05; #= p<0.05). 
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DISCUSSION 
 
 The current field of cartilage tissue engineering uses BMSCs and 
chondrocytes separately in a variety of scaffolds.  While these two cell sources 
are not new, their utility has not yet been optimized.   Many published works 
investigate one animal model and rarely do their results translate to other animal 
models.  One of the benefits of working with swine as a large animal model is 
that the biomechanical features of the knee joint are similar to that in humans.  
The gap between swine and human knee joints and the application of 
translational research therapies into the clinical setting is more easily managed. 
Comparison studies of cell sources have been carried out between swine 
and humans (Heino et al., 2012; Zhao et al., 2012).  More specifically, as Zhao et 
al. investigated, most patients in need of articular cartilage therapies are middle-
aged or older; thus facilitating the need for evaluation of elderly human articular 
chondrocytes.  Yet, for tissue engineering purposes, knowledge on the cellular 
potential of each species to form new tissue is highly important.  This will 
ultimately make the transition between research and clinical application quicker. 
 This study sought to deal specifically with the current shortfalls of AC 
therapy.  ACI is the most direct comparison of current surgical treatments to the 
field of tissue engineering.  Elderly human chondrocytes have been reported as 
capable of producing ECM (Zhao et al., 2012).  In addition to other problems 
mentioned earlier, acquisition of sufficient chondrocytes is a major limiting factor.  
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By combining swine BMSCs and chondrocytes into one gel, most obviously, the 
strict requirement of chondrocytes as the lone cell source is relieved.  Further, 
the potential for chondrocytes to direct the differentiation of BMSCs within the gel 
reduces the number of overall steps in the process for utilization of BMSCs as 
differentiated chondrocytes.  It has been shown that cultured chondrocytes can 
release the growth factors TGF-β3 (transforming growth factor beta 3) and IGF-1 
(insulin like growth factor), both of which have implications in directing BMSCs 
toward their chondrogenic lineage (Liu et al., 2012).  Thus, one of the aims in 
performing this co-culture study was to investigate the direct effect mature 
chondrocytes have on the chondrogenic potential of BMSCs in vivo.  
 This lab has extensive experience with various scaffolds purposed for 
articular cartilage engineering (Bichara et al., 2011, 2012; Papadopoulos et al., 
2011).  Alginate serves as a suitable scaffold for chondrocytes because it allows 
the cells to maintain their chondrocyte phenotype and retard dedifferentiation 
(Chung & Burdick, 2008). 
 The results from this study indicate that BMSCs co-cultured with 
chondrocytes in alginate do not offer a significant advantage in engineering 
neocartilage over alginate gels with BMSCs or chondrocytes alone.  Gross 
appearance showed some opaque formations in the BMSC and chondrocyte co-
culture gel and BMSC only gels (Figure 6).  The chondrocyte gel showed no 
visible opaque neocartilage formations macroscopically.  Yet, not surprisingly, 
this gel produced about 100% and 500% more sGAG and hydroxyproline 
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respectively than the other gels in the co-culture experiment (Figures 8 & 9).  
Overall, the alginate gels constructed for this study were relatively inferior when 
comparing quantitative biochemical data with that of previous studies performed 
in this lab (Papadopoulos et al., 2011).  Histological examination provided 
evidence of good ECM production, but could not be supported quantitatively 
when compared with native swine articular cartilage. 
 Histological evaluation of the BMSC and chondrocyte co-culture gel 
yielded no continuous ECM formation and many sections had to be cut before 
the presence of gel was detected.  By comparison, the BMSCs gels appeared 
superior in ECM production and neocartilage formation was continuous 
throughout the gels.  Chondrocyte gels showed pericellular ECM production only 
and limited continuous ECM formation (Figure 9).  Safranin-O stained 
chondrocyte gel (Figure 9, right) shows the only continuous ECM formation within 
that particular sample.  It is possible that the cell density for each of the different 
groups needs to be optimized before proper ECM production can occur.  Prior 
studies in this lab have investigated the effect of different chondrocyte seeding 
densities within scaffolds, namely fibrin (Silverman et al., 1999).  If the cell 
density is not high enough, pericellular ECM production dominates and never 
forms continuous neocartilage.  This gives the neotissue a bubbly appearance as 
ECM islands form around the cell and never coalesce into a continuous ECM 
(Figure 9).  Alternatively, if the cell density is high enough, continuous ECM 
forms neocartilage more similar to that of native cartilage.   
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 The integration of the BMSC gel with the devitalized cartilage ring 
appeared to be superior to all other groups (Figure 8).  Proper integration of 
engineered cartilage with native cartilage is important to prevent any proud 
edges that might be worn down through the normal shear stresses experienced 
by the articular surfaces in the knee.  The integration in the chondrocyte gel did 
not follow the entire length of the devitalized cartilage ring contact points (Figure 
9).  Interestingly, there appears to be a thin, fibrous layer of cells between the 
chondrocyte gel and the devitalized ring, not present in the integration of the 
BMSC gel.  No ECM accumulation directly around or within the thin layer of cells 
is evident.  It might be concluded that the ECM integration shown in the BMSC 
gel (Figure 8) results in a more cohesive and seamless transition of neocartilage 
and native cartilage.  One important point is that this study used devitalized 
cartilage rings and not living native cartilage.  The repeated freeze-thaw cycles 
killed the chondrocytes and matrix production ceased.  This allowed for a broader 
contrast when analyzing the alginate gels ECM production during histological 
evaluation.  The fact that some of the gels showed integration with the devitalized 
ring lends credence to the thought that integration with living cartilage would be 
more complete.  One of the innate capabilities of articular cartilage is the fact that 
they do not spontaneously heal and integration of engineered cartilage could 
make up for this. 
 The sGAG and hydroxyproline levels measured in the samples were 
significantly lower than that of native cartilage for the six week timepoint in this 
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study.  Levels were expected to be about 5-6 times higher.  According to 
previous papers in this lab, engineered cartilage constructs were capable of 
producing about 30μg sGAG/mg wet tissue and 5 μg hydroxyproline/mg wet 
tissue at 6 weeks in vivo  (Papadopoulos et al., 2011).  When the two week in 
vitro differentiation period is taken into account, the gels’ lifespan, from creation 
to analysis, was 8 weeks.  Still, the biochemical data did not yield expected 
results.  Part of this may have been due to the fact that one-fourth of each 
sample was used for each biochemical test.  Macroscopically, the neocartilage 
formation (Figure 6), was not evenly distributed throughout the gel and dispersion 
varied among quadrants of each gel.  Since there were only four samples per 
group, it seemed prudent to gather all endpoint data from each sample in an 
attempt to normalize the results.  This may have contributed to the lower than 
expected measurements of sGAG and hydroxyproline.  When compared to the 
chondrocyte gel, BMSCs produced about 50% of the sGAG levels.   
 The conditioned media alginate gels produced the best results when 
compared with the three groups from the co-culture experiment.  Histological 
comparison shows that the conditioned BMSCs produced the most continuous 
neocartilage.  Conditioned media BMSCs produced similar levels of sGAG and 
hydroxyproline in one less week in vivo.  During harvest of the samples, small 
calcifications were identified macroscopically, but could not be detected 
histologically.  Despite the excellent ECM production of these samples, 
calcifications could be the cause of an overexpression of collagen type X, 
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indicating hypertrophic mRNA levels (Caron et al., 2012).  It is possible that some 
of the effects are due to 2D monolayer culture of the BMSCs through three 
passages prior to suspension in a 3D alginate environment.   
 In summary, this study identified potential areas of interest in future 
pursuits of cartilage tissue engineering.  Despite the study’s limitations, it did 
identify specific strengths in the use of alginate as a scaffold for neocartilage 
formation.  The chondrogenic properties and supportive bone-marrow derived 
mesenchymal stem cell niche of alginate provides a foundation for future studies 
to build upon.  More specific aims need to be developed for future studies.  In 
searching for alternative cell sources, BMSCs are capable of bearing some of 
these requirements which chondrocytes in current therapies such as autologous 
chondrocyte implantation exhibit.  The transition to BMSCs as a replacement for 
chondrocytes is the ultimate goal and shown in this study to be an option worth 
pursuing.   
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